Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Benda, B.

Search results

  • RSS Feed
(1 - 5 of 5)
Remission At 3 Or 6 Months and Radiographic Non-Progression At 12 Months In Methotrexate-Naive Rheumatoid Arthritis Patients Treated With Tofacitinib Or Methotrexate: A Post-Hoc Analysis Of The ORAL Start Trial
Strand, V.; Heijde, D. van der; Landewe, R.; Lee, E.B.; Wilkinson, B.; Zwillich, S.H.; ... ; Gruben, D. 2013
Remission At 3 Or 6 Months and Radiographic Non-Progression At 12 Months In Methotrexate-Naive Rheumatoid Arthritis Patients Treated With Tofacitinib Or Methotrexate: A Post-Hoc Analysis Of The ORAL Start Trial
Article / Letter to editor
metadata only
TOFACITINIB MONOTHERAPY IS EFFECTIVE IN METHOTREXATE-NAIVE PATIENTS WITH DISEASE DURATION LESS THAN 6 MONTHS: A POST-HOC ANALYSIS OF EARLY RHEUMATOID ARTHRITIS SUBJECTS IN A PHASE 3 TRIAL
Huizinga, T.W.J.; Fleischmann, R.; Vollenhoven, R. van; Gruben, D.; Wilkinson, B.; Koncz, T.; ... ; Benda, B. 2013
TOFACITINIB MONOTHERAPY IS EFFECTIVE IN METHOTREXATE-NAIVE PATIENTS WITH DISEASE DURATION LESS THAN 6 MONTHS: A POST-HOC ANALYSIS OF EARLY RHEUMATOID ARTHRITIS SUBJECTS IN A PHASE 3 TRIAL
Article / Letter to editor
metadata only
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-fourmonth phase III randomized radiographic study
Heijde, D. van der; Tanaka, Y.; Fleischmann, R.; Keystone, E.; Kremer, J.; Zerbini, C.; ... ; ORAL Scan Investigators 2013
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-fourmonth phase III randomized radiographic study
Article / Letter to editor
metadata only
Tofacitinib, an Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: Year 2 Efficacy and Safety Results From a 24-Month Phase 3 Study
Heijde, D. van der; Tanaka, Y.; Fleischmann, R.M.; Keystone, E.; Kremer, J.M.; Zerbini, C.; ... ; ORAL Scan Investigators 2012
Tofacitinib, an Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: Year 2 Efficacy and Safety Results From a 24-Month Phase 3 Study
Article / Letter to editor
metadata only
Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: a 24-Month Phase 3 Study
Heijde, D. van der; Tanaka, Y.; Fleischmann, R.; Keystone, E.C.; Kremer, J.M.; Zerbini, C.A.F.; ... ; ORAL Scan Investigators 2011
Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: a 24-Month Phase 3 Study
Article / Letter to editor
metadata only